| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.009 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |